Quote in the article " If CYDY can secure approval for leronlimab, it would essentially make all HAART drugs currently under development obsolete and give the company a key first mover advantage"

Just be patient fellows and let all the wild SP swings subside with several key announcements and milestones come into play over next 2 months "Patience is Golden"